ESR1 and breast carcinoma: Indeed, this isoform or the estrogen receptor is mainly described in the literature for its antiproliferative effect on breast cancer cells [48], and a study by Wang and colleagues [49] showed that its expression is induced by STAT3 in pulmonary adenocarcinomas.